Skip to main content
Figure 5 | Molecular Cancer

Figure 5

From: Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma

Figure 5

Treatment with PGAM1-shRNA-a inhibited xenograft tumor growth and induced apoptosis in vivo. (A), tumor volume growth curve after tail intravenous injection for 20 days. PGAM1-shRNA-a treatment resulted in significantly decreased tumor growth compared with other control groups (p < 0.05). (B) & (C), a significant decrease of PGAM1 expression in tumor-bearing mice examined by immunohistochemical analysis (upper lane). Cell proliferation was obviously inhibited and apparent apoptosis was induced (p < 0.05). a, PBS; b, Lipofectamine 2000; c, shNC; d, PGAM1-shRNA-a. Data were shown as mean ± S.D.

Back to article page